Efficacy of Exercise for Sexual Side Effects of Antidepressants
Information source: University of Texas at Austin
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Sexual Dysfunction
Intervention: Exercise (Behavioral)
Phase: N/A
Status: Completed
Sponsored by: University of Texas at Austin Official(s) and/or principal investigator(s): Tierney K Ahrold Lorenz, M.A., Principal Investigator, Affiliation: University of Texas at Austin
Summary
The major aim of the this study is to replicate findings of previous research that examined
the effects of acute exercise on sexual arousal in women in a novel population, namely,
women taking antidepressants of the selective serotonin reuptake inhibitors (SSRI) or
selective serotonin and norepinephrine reuptake inhibitors (SNRI) class. In previous studies
it has been found that acute, moderate-intensity exercise facilitated physiological sexual
arousal responses in healthy, sexually functional women. However, it is known that
antidepressants may induce sexual dysfunction, and thus in the present study, the
investigators are examining whether acute exercise may facilitate sexual responses in women
with taking antidepressants, including women with antidepressant-related sexual dysfunction.
Clinical Details
Official title: Effects of Acute Exercise on Sexual Arousal in Women Taking a Selective Serotonin Reuptake Inhibitor (SSRI) or Selective Serotonin/Norepinephrine Reuptake Inhibitor
Study design: Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Primary outcome: Sexual arousal
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- female
- age 18 or older
- currently receiving a consistent dosage of escitalopram, citalopram, sertraline,
desvenlafaxine, venlafaxine, or duloxetine
- currently sexually active
- willing and able to exercise
- experiencing regular menstrual cycles
- not currently pregnant and not intending to become pregnant during trial
Exclusion Criteria:
- currently taking more than one psychoactive medication
- factors indicating risk of cardiovascular activity, including acute or chronic
cardiovascular illness, including clinically significant hypertension (defined as
self-reported hypertension or "blood pressure greater than 140/90" or receiving
medications designed to treat hypertension); recent chest pain; frequent or recurrent
faint or dizzy spells; severe or untreated exercise-related asthma; or
musculoskeletal illness or injury that would be expected to worsen with physical
exercise. Additionally, women will be excluded if they are found to have any of the
following as measured during the fitness assessment of the first session: a BMI over
40, waist circumference over 40 inches, waist-to-hip ratio of greater than 0. 9,
systolic blood pressure greater than 150 or diastolic pressure over 95, or resting
heart rate over 90.
- factors associated with significant genital nerve damage, including: previous major
pelvic surgery that may have caused nerve damage, including hysterectomy, vulvectomy,
circumcision, colostomy, cystostomy, or serious bladder, rectal, or abdominal
surgery; or neurological impairment due to diabetes, stroke, pelvic nerve damage
secondary to trauma, cancer treatments, myasthenia gravis, multiple sclerosis or
spinal cord damage.
- factors associated with non-normative endocrine function, including: perimenopausal
or menopausal status, or >1 missed menstrual period in the previous 6 months; or
currently pregnant, breastfeeding, or having breastfed within the past 3 months; or
reporting clinically significant untreated renal or endocrine disease
- untreated serious mental health conditions
- sexual aversion or distress due to history of unwanted sexual contact
Locations and Contacts
University of Texas at Austin, Austin, Texas 78712, United States
Additional Information
Laboratory webpage
Starting date: June 2009
Last updated: February 25, 2013
|